Hankang Capital
Hankang Capital is a privately held venture capital firm founded in 2010 and headquartered in China. The firm focuses on investing in the pharmaceutical, biotech, and medical device industries, with a specialization in conducting in-depth research into major diseases and unmet clinical needs. Hankang Capital promotes the establishment of startups with first-tier teams and technology platforms, and provides professional insights, experience, and resources to its portfolio companies to help them succeed. The firm has invested in several industry-leading companies and has been recognized as one of the Top 100 Venture Capital Institutions and Top 20 Investment Institutions in the Healthcare Sector by the Zero2IPO Group.